Dyspepsia
Dyspepsia covers pain, fullness, early satiety, bloating, and nausea. It can
occur with gastric and duodenal ulceration (section 1.3) and gastric cancer but most commonly it is of
uncertain origin.
Urgent endoscopic investigation is required if dyspepsia is accompanied by ‘alarm features’ (e.g. bleeding, dysphagia, recurrent vomiting, or weight loss). Urgent investigation should also be considered for patients over 55 years with unexplained dyspepsia that has not responded to treatment.
Patients with dyspepsia should be advised about lifestyle changes (see Gastro-oesophageal reflux disease, below). Some medications may cause dyspepsia—these should be stopped, if possible. Antacids may provide some symptomatic relief.
If symptoms persist in uninvestigated dyspepsia, treatment involves a proton pump inhibitor (section 1.3.5) for 4 weeks. A proton pump inhibitor can be used intermittently to control symptoms long-term. Patients with uninvestigated dyspepsia, who do not respond to an initial trial with a proton pump inhibitor, should be tested for Helicobacter pylori and given eradication therapy (section 1.3) if H. pylori is present. Alternatively, particularly in populations where H. pylori infection is more likely, the ‘test and treat’ strategy for H. pylori can be used before a trial with a proton pump inhibitor.
If H. pylori is present in patients with functional (investigated, non-ulcer) dyspepsia, eradication therapy should be provided. However, most patients with functional dyspepsia do not benefit symptomatically from H. pylori eradication. If symptoms persist, treatment with either a proton pump inhibitor (section 1.3.5) or a histamine H2-receptor antagonist (section 1.3.1) can be given for 4 weeks. These antisecretory drugs can be used intermittently to control symptoms long-term
Urgent endoscopic investigation is required if dyspepsia is accompanied by ‘alarm features’ (e.g. bleeding, dysphagia, recurrent vomiting, or weight loss). Urgent investigation should also be considered for patients over 55 years with unexplained dyspepsia that has not responded to treatment.
Patients with dyspepsia should be advised about lifestyle changes (see Gastro-oesophageal reflux disease, below). Some medications may cause dyspepsia—these should be stopped, if possible. Antacids may provide some symptomatic relief.
If symptoms persist in uninvestigated dyspepsia, treatment involves a proton pump inhibitor (section 1.3.5) for 4 weeks. A proton pump inhibitor can be used intermittently to control symptoms long-term. Patients with uninvestigated dyspepsia, who do not respond to an initial trial with a proton pump inhibitor, should be tested for Helicobacter pylori and given eradication therapy (section 1.3) if H. pylori is present. Alternatively, particularly in populations where H. pylori infection is more likely, the ‘test and treat’ strategy for H. pylori can be used before a trial with a proton pump inhibitor.
If H. pylori is present in patients with functional (investigated, non-ulcer) dyspepsia, eradication therapy should be provided. However, most patients with functional dyspepsia do not benefit symptomatically from H. pylori eradication. If symptoms persist, treatment with either a proton pump inhibitor (section 1.3.5) or a histamine H2-receptor antagonist (section 1.3.1) can be given for 4 weeks. These antisecretory drugs can be used intermittently to control symptoms long-term